TYP
Click for more information
0.00% 1.8¢ tryptamine therapeutics limited

codiak share price, page-7

  1. oaftar
    6,206 Posts.
    lightbulb Created with Sketch. 27
    clock Created with Sketch.
    26/01/22
    08:02
    Post #: 59135060
    codiak getting smashed. Down another ten percent. Why?

    are they going out of business?
    EX1 Price at posting: 40.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
right-arrow Created with Sketch.
NEWS High-grade drill results confirm extension at Paddy’s Lodes—reinforcing significant discovery and growth potential at Youanmi Gold Project
right-arrow Created with Sketch.
NEWS Waroona Project financing strategy aims for non-dilutive funding solutions - discover how this approach will support its Stage One development
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
1.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $19.60M
Open High Low Value Volume
1.9¢ 1.9¢ 1.8¢ $2.183K 120.7K

Buyers (Bids)

No. Vol. Price($)
2 117646 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 695000 1
View Market Depth
Last trade - 15.58pm 04/10/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.